Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Induced Pluripotent Stem Cell Market 2022 – By Derived Cell Type (Blood Cells, Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell & Gene Therapy), By End-User (Hospitals, Research Laboratories), And By Region, Opportunities And Strategies – Global Forecast To 2031

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

Starting Price : $5000.00 $3500.00 | Pages : 276 | Published : October 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Induced Pluripotent Stem Cell (iPSC) Market Definition

The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as hepatocytes, fibroblasts, keratinocytes, and neurons.

Induced pluripotent stem cell (iPSC) are derived from somatic cells such as skin or blood cells that have been reprogrammed, by ectopic introduction of transcriptional factor genes, back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes.

Book your 30 minutes free consultation with our research experts

Contact Us

Induced Pluripotent Stem Cell (iPSC) Market Size

The global induced pluripotent stem cell (iPSC) market size reached a value of nearly $2,431.2 million in 2021, having increased at a compound annual growth rate (CAGR) of 10.8% since 2016. The market is expected to grow from $2,431.2 million in 2021 to $3,997.5 million in 2026 at a rate of 10.5%. The global induced pluripotent stem cell (iPSC) market size is then expected to grow at a CAGR of 9.2% from 2026 and reach $6,195.8 million in 2031.  

Growth in the historic period resulted from increased healthcare expenditure, a rise in funding, the development of non-animal alternatives for preclinical drug research, reduced cost for drug discovery and increasing demand for personalized medicine. Factors that negatively affected growth in the historic period were the lack of awareness on induced pluripotent stem cells and inadequate reimbursements.

Going forward, increasing prevalence of chronic diseases, growth in genomic projects, development of iPSC-derived disease models, increasing funding and increasing prevalence of genetic diseases will drive market growth. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include automation of iPSC production, the risk associated with induced pluripotent stem cell treatment, high cost associated with storage, low per capita healthcare expenditure and disruption of medical facilities due to Russia-Ukraine war and the coronavirus pandemic.

Induced Pluripotent Stem Cell (iPSC) Market Drivers

The key drivers of the induced pluripotent stem cell (iPSC) market include:

Increasing Prevalence Of Chronic Diseases

  • Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. With induced pluripotent stem cells, chronic diseases like diabetes, cancer, cancer, and stroke can be treated. Any tissue from a child or adult can be used to create induced pluripotent stem cells, which are genetically altered to act like embryonic stem cells.

  • it has been calculated that, in 2021, chronic diseases impacted total reported deaths in the world around 60% of the $56.5 million and approximately 46% of the global burden of disease. This rise in incidences of chronic diseases is expected to drive the demand for induced pluripotent stem cell treatment in the forecast period.

    • Induced Pluripotent Stem Cell (iPSC) Market Restraints

    The key restraints on the induced pluripotent stem cell (iPSC) market include:

    Automation Of iPSC Production

  • Automation in the production of induced pluripotent stem cells (iPSC) is expected to inhibit the growth of the market.

  • There is a deficiency in industrial processes for large scale production of human iPS cells for drug development. One reason is the high complexity of the manual processes involved and the need for highly qualified and experienced laboratory staff.

  • Established biotechnological methods aim for a large scale production of one specific cell type. The iPS cell technology however demands the production, generation and differentiation of large numbers of individual iPS cell clones with the respective quality control.

  • The transfer of manual laboratory processes for reprogramming, selection and expansion to an automatic production process requires innovative solutions when it comes to the system control unit. A major challenge is the systematic parallelization of all biotechnological production steps.

  • Therefore, the adaptation of iPS cell production to industrial formats and automatic process steps for high throughput screening (HTS) has remained a major challenge, limiting market growth.
    •    

    Induced Pluripotent Stem Cell (iPSC) Market Trends

    Major trends influencing the induced pluripotent stem cell (iPSC) market include:

    Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)

  • Use of pluripotent stem cells in treating Parkinson’s Disease (PD) is key trend gaining popularity in induced pluripotent stem cell (iPSC) market. Extensive research is being conducted on the use of induced pluripotent stem cells to treat Parkinson’s disease (PD). A neurodegenerative condition called Parkinson's disease (PD) affects the nerve cells responsible for producing dopamine. Parkinson's disease may one day be treated by converting mature skin cells into nerve cells with the ability to create dopamine, or "induced pluripotent nerve cells" (PD).

  • For instance, in April 2022, Aspen Neuroscience, Inc, a US-based biotechnology company, first autologous neuron replacement for Parkinson's disease using induced pluripotent stem cells (iPSCs) (PD), launched clinical trial's first patient screening study of Parkinson's disease personalized cell replacement.

  • For instance, in June 2022, BlueRock Therapeutics, Germany based, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, established expansion of the development of cell treatments in BlueRock's pipeline, with an initial focus on the ongoing BRT-DA01 clinical trial in Parkinson's disease. The creation of a BlueRock site in Berlin enhances the company's footprint and strengthens Bayer's cell therapy capabilities.

    • Strategic Collaborations And Partnerships

  • Major companies operating in the induced pluripotent stem cell (iPSC) market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market. Companies are creating novel items and exchanging knowledge and skills with other businesses. While businesses and academic and research organisations have long worked together in this sector through partnerships and out- or in-licensing agreements.

  • For instance, in November 2020, FUJIFILM Cellular Dynamics, Inc., a US-based developer and manufacturer of human-induced pluripotent stem cells (iPSCs) announced that the US-based GMP iPSC manufacturer Lonza Walkersville, Inc., it has reached a global agreement. In the partnership, FUJIFILM Cellular Dynamics grants Lonza a non-exclusive licence to use its iPSC generation patents, and Lonza grants FUJIFILM Cellular Dynamics expanded use of its innovative NucleofectorTM technology. Through licencing agreements, the two companies combine their resources to create human induced pluripotent stem cells.

  • For instance, in September 2021, Bone Therapeutics, developing novel treatments to meet significant unmet needs in orthopaedics and other disorders is the goal of a biotech company, partnered with Implant Therapeutics. The collaboration will make Implant Therapeutics induced pluripotent stem cell (iPSC) lines, medium, differentiation techniques, and expertise available to Bone Therapeutics for access, evaluation, and material transfer. Implant Therapeutics, a US-based company, creator of safe harbor designed iPSC generated cells and hypoimmunogenic cells.

    • Opportunities And Recommendations In The Induced Pluripotent Stem Cell (iPSC) Market

    Opportunities –The top opportunities in the induced pluripotent stem cell (iPSC) market by derived cell type will arise in the fibroblasts market, which will gain $456.5 million of global annual sales by 2026. The top opportunities in the induced pluripotent stem cell (iPSC) market by application will arise in the drug discovery & toxicity studies market, which will gain $710.9 million of global annual sales by 2026. The top opportunities in the induced pluripotent stem cell (iPSC) market by end-user will arise in the research laboratories market, which will gain $1,018.1 million of global annual sales by 2026. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $253.7 million.

    Recommendations –To take advantage of the opportunities, The Business Research Company recommends the induced pluripotent stem cell (iPSC) companies to focus on pluripotent stem cells for treating Parkinson’s disease, focus on development of induced pluripotent stem cell (iPSC)-derived NK cells, focus on induced pluripotent stem cell (iPSC) for cell therapy, focus on use of pluripotent stem cells in treating type 1 diabetes, expand in emerging economies, continue to focus on developed markets, focus on strategic partnerships and collaborations, offer competitive prices, continue to use B2B promotions, continue to participate in events and conferences and target fast-growing applications.

    Induced Pluripotent Stem Cell (iPSC) Market Segmentation

    The induced pluripotent stem cell (iPSC) market is segmented by derived cell type, by application, by end-user.
    By Derived Cell Type –
    The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into
      • a) Blood Cells
      • b) Hepatocytes
      • c) Fibroblasts
      • d) Keratinocytes
      • e) Amniotic Cells
      • f) Others
    The fibroblasts market was the largest segment of the induced pluripotent stem cell (iPSC) market by type, accounting for $728.0 million or 29.9% of the total market in 2021. The others market is expected to be the fastest-growing segment going forward at a CAGR of 12.3%.
    By Application–
    The induced pluripotent stem cell (iPSC) market is segmented by application into
      • a) Academic Research
      • b) Drug Discovery And Toxicity Studies
      • c) Regenerative Medicine
      • d) Cell & Gene Therapy
    The drug discovery and toxicity studies market was the largest segment of the induced pluripotent stem cell (iPSC) market by application, accounting for $1,178.3 million or 48.5% of the total market in 2021. The cell & gene therapy market is expected to be the fastest-growing segment going forward at a CAGR of 12.0%.
    By End-User –
    The induced pluripotent stem cell (iPSC) market is segmented by end-user into
      • a) Hospitals
      • b) Research Laboratories
    The research laboratories market was the largest segment of the induced pluripotent stem cell (iPSC) market by end user, accounting for $1,658.7 million or 68.2% of the total market in 2021. The hospitals market is expected to be the fastest-growing segment going forward at a CAGR of 11.3%.
    By Geography- The induced pluripotent stem cell (iPSC) market is segmented by geography into
      • o Asia Pacific
        • •  China
        • •  Japan
        • •  India
        • •  Australia
        • •  Indonesia
        • •  South Korea
        • o North America
        • • USA
        o South America
        • • Brazil 
        o Western Europe
        • • UK 
        • • Germany 
        • • France 
        o Eastern Europe
        • • Russia 
        o Middle East
        o Africa
    North America was the largest region in the global induced pluripotent stem cell (iPSC) market report, accounting for 48.9% of the global market in 2021. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the global induced pluripotent stem cell (iPSC) market will be South America and the Middle East, where growth will be at CAGRs of 35.1% and 33.5% respectively from 2021-2026.

    Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape

    Major Competitors are:

  • FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc)
  • Thermo Fisher Scientific, Inc
  • Takara Bio, Inc
  • Lonza Group AG
  • Astellas Pharma Inc

    • Other Competitors Include:

  • ViaCyte, Inc
  • Ncardia
  • REPROCELL USA, Inc
  • Japan Tissue Engineering Co., Ltd
  • Merck KGaA
  • Cynata Therapeutics Limited,
  • Shenzhen Bioscience,
  • Dainippon Sumitomo Pharma
  • Shanghai Cell Therapy Group
  • Car-T Bio
  • JW therapeutics
  • Fosun Kite Biotechnology
  • Shanghai UniCar Therapy
  • SEED Biosciences SA
  • Cellerix
  • CellGenix
  • NsGene
  • TiGenix
  • Renuron Group
  • Smart Cells
  • Genenta Science
  • Biocad Rf
  • Msd
  • Pfizer
  • Roche
  • Pharmasyntez
  • Selvita
  • Mabion
  • Pure Biologics
  • OncoArendi Therapeutics
  • Proteon Pharmaceuticals
  • GlaxoSmithKline
  • Parexel
  • Bayerare
  • Fate Therapeutics
  • Sangamo Therapeutics
  • Athersys
  • BrainStorm Cell Therapeutics
  • Cellular Biomedicine Group
  • Pluristem Therapeutics
  • Gamida Cell
  • VistaGen Therapeutics
  • Caladrius Biosciences
  • ThermoGenesis Holdings
  • BioCanRx
  • CellCAN
  • CCRM
  • C3i
  • BioCells Argentina
  • Banco de Cordon del Peru
  • CryoHoldco
  • CellSave Arabia
  • LifeCell
  • AmiCare
  • Cells4life
  • Smart Cells
  • CellSave
  • ReeLabs
  • StemCells
  • Royan Stem Cell Technology Co
  • Next BioSciences
  • CryoSave
  • BioHeart
  • StemCell Technologies
  • NetCells

      • Table Of Contents

      1. Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction and Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition and Segmentations

      6.4. Market Segmentation By Derived Cell Type

      6.4.1. Blood Cells

      6.4.2. Hepatocytes

      6.4.3. Fibroblasts

      6.4.4. Keratinocytes

      6.4.5. Amniotic

      6.4.6. Others

      6.5. Market Segmentation By Application

      6.5.1. Academic Research

      6.5.2. Drug Discovery And Toxicity Studies

      6.5.3. Regenerative Medicine

      6.5.4. Gene & Cell Therapy

      6.6. Market Segmentation By End-User

      6.6.1. Hospitals

      6.6.2. Research Laboratories

      7. Major Market Trends

      7.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)

      7.2. Strategic Collaborations And Partnerships

      7.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells

      7.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy

      7.5. Investment In Regenerative Medicine Research And Development

      7.6. Advancements In Technology Transfer And Clinical Translation

      7.7. Use of Pluripotent Stem Cells in treating Type 1 Diabetes

      8. Global Market Size And Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      8.2.1. Market Drivers 2016 – 2021

      8.2.2. Market Restraints 2016 – 2021

      8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      8.3.1. Market Drivers 2021 – 2026

      8.3.2. Market Restraints 2021 – 2026

      9. Global Market Segmentation

      9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10. Global Market, Regional And Country Analysis

      10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Taxes Levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.7. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      11.8. China Market

      11.9. Summary

      11.10. Market Overview

      11.10.1. Country Information

      11.10.2. Market Information

      11.10.3. Background Information

      11.10.4. Government Initiatives

      11.10.5. Regulations

      11.10.6. Regulatory Bodies

      11.10.7. Major Associations

      11.10.8. Taxes Levied

      11.10.9. Corporate Tax Structure

      11.10.10. Investments

      11.10.11. Major Companies

      11.11. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.15. India Market

      11.16. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.17. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.20. Japan Market

      11.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.23. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.25. Australia Market

      11.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.28. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.29. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.30. Indonesia Market

      11.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.32. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.33. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.34. South Korea Market

      11.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.37. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.38. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      12.8. UK Market

      12.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.13. Germany Market

      12.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.18. France Market

      12.19. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.20. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes levied

      13.2.9. Corporate tax structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      13.8. Russia Market

      13.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes levied

      14.2.9. Corporate tax structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.7. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      14.8. USA Market

      14.9. Summary

      14.10. Market Overview

      14.10.1. Country Information

      14.10.2. Market Information

      14.10.3. Background Information

      14.10.4. Government Initiatives

      14.10.5. Regulations

      14.10.6. Regulatory Bodies

      14.10.7. Associations

      14.10.8. Taxes Levied

      14.10.9. Corporate Tax Structure

      14.10.10. Investments

      14.10.11. Major Companies

      14.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.7. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      15.8. Brazil Market

      15.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory bodies

      16.2.7. Major Associations

      16.2.8. Taxes levied

      16.2.9. Corporate tax structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory bodies

      17.2.7. Major Associations

      17.2.8. Taxes levied

      17.2.9. Corporate tax structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Competitive Landscape And Company Profiles

      19. Company Profiles

      19.1. FUJIFILM Holdings Corporation

      19.1.1. Company Overview

      19.1.2. Products And Services

      19.1.3. Business Strategy

      19.1.4. Financial Overview

      19.2. Thermo Fisher Scientific, Inc

      19.2.1. Company Overview

      19.2.2. Products And Services

      19.2.3. Business Strategy

      19.2.4. Financial Overview

      19.3. Takara Bio, Inc

      19.3.1. Company Overview

      19.3.2. Products And Services

      19.3.3. Business Strategy

      19.3.4. Financial Overview

      19.4. Lonza Group AG

      19.4.1. Company Overview

      19.4.2. Products And Services

      19.4.3. Business Strategy

      19.4.4. Financial Overview

      19.5. Astellas Pharma Inc

      19.5.1. Company Overview

      19.5.2. Products And Services

      19.5.3. Business Strategy

      19.5.4. Financial Overview

      20. Key Mergers and Acquisitions

      20.1. Vertex Pharmaceuticals Acquired ViaCyte

      20.2. Medipost Acquired OmniaBio

      20.3. Catalent Acquired RheinCell Therapeutics

      20.4. Selvita Acquired Fidelta from Galapagos

      20.5. Bayer Acquired Asklepios BioPharmaceutical (AskBio)

      20.6. Boehringer Ingelheim Acquired Global Stem Cell Technology (GST)

      20.7. Vertex Pharmaceuticals Acquired Semma Therapeutics

      21. Opportunities And Strategies

      21.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Countries Offering Most New Opportunities

      21.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Segments Offering Most New Opportunities

      21.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Growth Strategies

      21.3.1. Market Trend Based Strategies

      21.3.2. Competitor Strategies

      22. Biotechnology Services Market, Conclusions And Recommendations

      22.1. Conclusions

      22.2. Recommendations

      22.2.1. Product

      22.2.2. Place

      22.2.3. Price

      22.2.4. Promotion

      22.2.5. People

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. The Business Research Company

      23.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 14: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 17: Asia-Pacific, Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 18: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 19: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 20: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 21: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 22: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 23: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 24: China Population By Age Group, 2016-2026, Thousands
    • Table 25: China GDP Per Capita, 2016-2021, $
    • Table 26:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 27: China Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 28: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 29: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 30: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 31: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 32: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 33: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 34: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 35: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 36: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 41: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 47: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 48: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 49: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 50: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 53: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 54: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 55: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 56: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 57: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 58: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 59: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 60: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 61: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 62: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 63: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 64: Western Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 65:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 66:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 67: Western Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 68: Western Smart Europe Washing Machines Market, Historic, 2016 – 2021, $ Million
    • Table 69: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 70: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 71: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 72: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 73: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 74: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 75: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 76: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 77: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 78: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 81: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 82: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 83: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 84: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 85: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 86: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 87: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 88: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 89: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 90: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 91: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 92: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 93: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 94:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 95:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 96: Eastern Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 97: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 98: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 99: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 100: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 101: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 102: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 103: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 104: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 105: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 106: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 107: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 108: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 109: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 110: North America GDP Per Capita, By Country, 2016-2021, $
    • Table 111:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 112:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 113: North America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 114: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 115: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 116: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 117: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 118: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 119: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 120: USA Population By Age Group, 2016-2026, Thousands
    • Table 121: USA GDP Per Capita, 2016-2021, $
    • Table 122:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 123: USA Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 124: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 125: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 126: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 127: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 128: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 129: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 130: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 131: South America GDP Per Capita, By Country, 2016-2021, $
    • Table 132:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 133:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 134: South America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 135: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 136: South America Washing Machines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 137: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 138: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 139: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 140: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 141: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 142: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 143: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 144: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 145: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 146: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 147: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 148: Middle East GDP Per Capita, By Country, 2016-2021, $
    • Table 149:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 150:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 151: Middle East Healthcare Services Market Size, 2016-2021, $ Billion
    • Table 152: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
    • Table 153: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 154: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 155: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 156: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 157: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 158: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 159: Africa GDP Per Capita, By Country, 2016-2021, $
    • Table 160:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 161:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 162: Africa Healthcare Services Market Size, 2016-2021, $ Billion
    • Table 163: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 164: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 165: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 166: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 167: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 168: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 169: Fujifilm Holding’s – Financial Performance, 2017– 2021, $ Billion
    • Table 170: Thermo Fisher – Financial Performance, 2017-2021, $ Billion
    • Table 171: Lonza – Financial Performance, 2017 – 2021, $ Billion
    • Table 172: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 173: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Derived Cell Type, 2021 – 2026
    • Table 174: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
    • Table 175: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By End-Use Industry, 2021 – 2026
    • Table 176: Induced Pluripotent Stem Cell (iPSC) Market Data Sources

    List Of Figures

      Figure 1: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By Derived Cell Type
    • Figure 2: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By Application
    • Figure 3: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By End-Use Industry
    • Figure 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 35: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 39: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 40: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 43: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 45: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 51: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 55: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 59: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 60: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 63: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 64: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 67: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 68: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 71: South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 72: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 73: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 75: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 76: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 79: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 80: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 84: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 85: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 86: Fujifilm Holding Corporation – Financial Performance, 2015 – 2019, $ Billion
    • Figure 87: Thermo Fisher Scientific Inc.– Financial Performance, 2016 – 2020, $ Billion
    • Figure 88: Takara Bio Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 89: Fate Therapeutics – Financial Performance, 2016 – 2020, $ Million

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the antivirals market research report 2022 with industry size, share, segments and market growth

    Read More

    Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 – By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy), By End-User (Hospitals, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Rituximab Biosimilars Market 2021 - By Application (Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Mail Orders) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Acne Drugs Market 2021 - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics), By Therapeutic Class (Benzoyl Peroxide, Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Cell And Gene Therapy Market 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    HIV Drugs Market 2021 - By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs)) By Application (Hospital Pharmacies, Retail Pharmacies) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Microbiome Market 2022 – By Type (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Microbiome Therapeutic (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Others), By Microbiome Diagnostic (Genomics, Proteomics, Metabolomics), By End-Use (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases), By Technology (Genomics, Proteomics, Metabolomics), And By Region, Opportunities And Strategies – Global Forecast To 2031

    View Report

    Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

    View Report

    Frequently Asked Questions

    What is the definition of the induced pluripotent stem cell market?

    The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as hepatocytes, fibroblasts, keratinocytes, and neurons. request a sample here

    How will the induced pluripotent stem cell market drivers and restraints affect induced pluripotent stem cell market dynamics? What forces will shape the induced pluripotent stem cell industry going forward?

    The induced pluripotent stem cell market growth is aided by increasing prevalence of chronic diseases. However, some induced pluripotent stem cell market restraints include the risk associated with induced pluripotent stem cell treatment request a sample here

    What is the forecast market size of the induced pluripotent stem cell market?

    The induced pluripotent stem cell market forecast is expected to reach $4,547.7 million in 2030 at a compound annual growth rate of 6.2%. request a sample here

    How is the induced pluripotent stem cell market segmented?

    The global induced pluripotent stem cell market is segmented -
    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others
    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Cell & Gene Therapy, Regenerative Medicine
    3) By End-User: Research Laboratories, Hospitals     request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the induced pluripotent stem cell global market report?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    Who are the key players of the global induced pluripotent stem cell market?

    Top competitors in the induced pluripotent stem cell market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., ViaCyte, Fate Therapeutics request a sample here.

    What are the key trends in the global induced pluripotent stem cell market?

    Major trends influencing the induced pluripotent stem cell market include use of pluripotent stem cells in treating parkinson’s disease (pd) request a sample here.

    What are the major opportunities in the induced pluripotent stem cell market and the approaches companies can take to take advantage of them?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    How does the induced pluripotent stem cell market relate to the overall economy and other similar markets?

    request a sample here.

    request a sample here.

    request a sample here.